As the peak hayfever season arrives, Piriteze Allergy Tablets is the next product to feature in GlaxoSmithKline (GSK)’s £3.3 million advertising campaign, following activity for Pirinase earlier in the season. Piriteze Allergy Tablets will feature on TV, digital and out-of-home platforms from the start of May. GSK hopes the overall campaign will drive awareness of the allergy category and remind customers of the range of products available within the Piri portfolio for relieving hayfever symptoms.

GlaxoSmithKline: 0800 783 8881